Forbion Growth Opportunities Fund III Cooperatief U.A.
SEC insider (Form 3/4/5 filer). CIK 0002050895. 10% Owner at Braveheart Bio, Inc. (BRVE). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in NAARDEN.
Companies Forbion Growth Opportunities Fund III Cooperatief U.A. has filed insider reports for
- Braveheart Bio, Inc. (BRVE): 10% Owner
Forbion Growth Opportunities Fund III Cooperatief U.A.
CIK: 0002050895
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRVE
Braveheart Bio, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 7, 2026BRVE
Braveheart Bio, Inc.
ConversionDirect9.1M shares- - Aug 7, 2026BRVE
Braveheart Bio, Inc.
ConversionIndirect8M shares- - Aug 7, 2026BRVE
Braveheart Bio, Inc.
PurchaseDirect1.9M shares at avg. $18.00$34.6M - Aug 7, 2026BRVE
Braveheart Bio, Inc.
PurchaseIndirect1.7M shares at avg. $18.00$30.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Conversion | 9,132,420 | - | $0 | Direct |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Conversion | 7,990,867 | - | $0 | Indirect |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Purchase | 1,920,000 | $18.00 | $34,560,000 | Direct |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | Purchase | 1,680,000 | $18.00 | $30,240,000 | Indirect |
1-4 of 4 transactions